Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harenberg

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Anaesthesia|July 17, 2009
Thrombelastometer and low molecular weight heparinJ Harenberg
Journal Des Maladies Vasculaires|January 1, 1987
Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparinsJ Harenberg
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Is laboratory monitoring of low-molecular-weight heparin therapy necessary? YesJ Harenberg
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients: a rebuttalJ Harenberg
Thrombosis Research|February 11, 2009
LMWH - new mechanisms of actionJ Harenberg
Zentralblatt Fur Chirurgie|January 1, 1994
[Prevention of thrombosis in minimally invasive surgery]J Harenberg
Zeitschrift Fur Kardiologie|January 1, 1993
[Therapy of thrombosis with conventional heparin]J Harenberg
Haemostasis|January 1, 1988
Relation of antifactor Xa activity of heparins and antithrombotic efficacyJ Harenberg
Medicinal Research Reviews|January 22, 1998
Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexideJ Harenberg
Zeitschrift Fur Kardiologie|December 19, 1998
[Anticoagulation in patients with heart valve replacement in pregnancy]J Harenberg
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Anaesthesia|July 17, 2009
Thrombelastometer and low molecular weight heparinJ Harenberg
Journal Des Maladies Vasculaires|January 1, 1987
Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparinsJ Harenberg
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Is laboratory monitoring of low-molecular-weight heparin therapy necessary? YesJ Harenberg
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients: a rebuttalJ Harenberg
Thrombosis Research|February 11, 2009
LMWH - new mechanisms of actionJ Harenberg
Zentralblatt Fur Chirurgie|January 1, 1994
[Prevention of thrombosis in minimally invasive surgery]J Harenberg
Zeitschrift Fur Kardiologie|January 1, 1993
[Therapy of thrombosis with conventional heparin]J Harenberg
Haemostasis|January 1, 1988
Relation of antifactor Xa activity of heparins and antithrombotic efficacyJ Harenberg
Medicinal Research Reviews|January 22, 1998
Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexideJ Harenberg
Zeitschrift Fur Kardiologie|December 19, 1998
[Anticoagulation in patients with heart valve replacement in pregnancy]J Harenberg
Pageof 20